Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Opium Use and Subsequent Incidence of Cancer: Results From the Golestan Cohort Study Publisher Pubmed



Sheikh M1, 4 ; Shakeri R1 ; Poustchi H2, 3 ; Pourshams A1, 3 ; Etemadi A1, 5 ; Islami F1, 6 ; Khoshnia M1, 7 ; Gharavi A1, 7 ; Roshandel G1, 7 ; Khademi H1 ; Sepanlou SG3 ; Hashemian M1, 10 ; Fazel A8 ; Zahedi M9 Show All Authors
Authors
  1. Sheikh M1, 4
  2. Shakeri R1
  3. Poustchi H2, 3
  4. Pourshams A1, 3
  5. Etemadi A1, 5
  6. Islami F1, 6
  7. Khoshnia M1, 7
  8. Gharavi A1, 7
  9. Roshandel G1, 7
  10. Khademi H1
  11. Sepanlou SG3
  12. Hashemian M1, 10
  13. Fazel A8
  14. Zahedi M9
  15. Abediardekani B4
  16. Boffetta P11, 12
  17. Dawsey SM5
  18. Pharoah PD13
  19. Sotoudeh M1
  20. Freedman ND5
  21. Abnet CC5
  22. Day NE13
  23. Brennan P4
  24. Kamangar F14
  25. Malekzadeh R1, 2, 3

Source: The Lancet Global Health Published:2020


Abstract

Background: Evidence is emerging for a role of opiates in various cancers. In this study, we aimed to investigate the association between regular opium use and cancer incidence. Methods: This study was done in a population-based cohort of 50 045 individuals aged 40–75 years from northeast Iran. Data on participant demographics, diet, lifestyle, opium use, and different exposures were collected upon enrolment using validated questionnaires. We used proportional hazards regression models to estimate hazard ratios (HRs) and corresponding 95% CIs for the association between opium use and different cancer types. Findings: During a median 10 years of follow-up, 1833 participants were diagnosed with cancer. Use of opium was associated with an increased risk of developing all cancers combined (HR 1·40, 95% CI 1·24–1·58), gastrointestinal cancers (1·31, 1·11–1·55), and respiratory cancers (2·28, 1·58–3·30) in a dose-dependent manner (ptrend<0·001). For site-specific cancers, use of opium was associated with an increased risk of developing oesophageal (1·38, 1·06–1·80), gastric (1·36, 1·03–1·79), lung (2·21, 1·44–3·39), bladder (2·86, 1·47–5·55), and laryngeal (2·53, 1·21–5·29) cancers in a dose-dependent manner (ptrend<0·05). Only high-dose opium use was associated with pancreatic cancer (2·66, 1·23–5·74). Ingestion of opium (but not smoking opium) was associated with brain (2·15, 1·00–4·63) and liver (2·46, 1·23–4·95) cancers in a dose-dependent manner (prend<0·01). We observed consistent associations among ever and never tobacco users, men and women, and individuals with lower and higher socioeconomic status. Interpretation: Opium users have a significantly higher risk of developing cancers in different organs of the respiratory, digestive, and urinary systems and the CNS. The results of this analysis show that regular use of opiates might increase the risk of a range of cancer types. Funding: World Cancer Research Fund International, Cancer Research UK, Tehran University of Medical Sciences, US National Cancer Institute, International Agency for Research on Cancer. © 2020 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY-NC-ND 3.0 IGO license which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is properly cited. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL
Other Related Docs
13. Overexpression of Adiponectin Receptors in Opium Users With and Without Cancer, Clinical Pharmacology: Advances and Applications (2020)
15. Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma, International Journal of Cancer (2021)
16. Opium Addiction and Risk of Laryngeal and Esophageal Carcinoma, Iranian Journal of Otorhinolaryngology (2017)